Immunological and Cellular Strategies in Metabolic Disease (King's and Technische Universität Dresden) PhD

Overview

King's College London (KCL) and the Technische Universität Dresden (TUD) and  are experts in identifying and modifying immunological processes relevant to the pathophysiology of Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D).

Both academic institutions are leading islet transplantation centres and have been pioneering new interventional strategies for the treatment of both types of diabetes and the metabolic syndrome, including metabolic surgery. This expertise will be combined within the overarching IRTG to advance the joint, key research goals; namely, 'Recognition, regeneration and cell replacement in T1D' and the second, 'Systems biology in T2D”.

This 4-year PhD Programme offers the opportunity to complete a degree within these research areas in constant interaction between the UK-based and Germany-based partner labs. There are 12 research groups in each campus, London and Dresden, each comprising of 13 researchers. Students are given the additional option for a joint PhD award. 

For more information please visit the Programme webpage.

Entry accepted twice a year in January and September. 

To study at King's, it is essential that you can communicate effectively in English and are able to do so in an academic environment. You are usually required to provide certification of your competence in English before starting your studies.

• register on the King's Apply Portal
• complete our online application form